Publication | Open Access

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

MedicineImmunologyPathologyColorectal CancerPembrolizumab Versus ChemotherapyCancer GenomicsImmune Checkpoint InhibitorCancer GeneticsOncologyRadiation OncologyMolecular OncologyFinal Analysis